TOM GUGEL: Open Payments
NPI 1417719626 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$118 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $118
Food & beverage: $118
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TRINTELLIX, ZENPEP, Jornay PM, ARISTADA, XIFAXAN.
Industry payments across CT — which companies pay providers there.
